MRI (Magnetic Resonance Imaging) — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a powerful static magnetic field (typically 1.5 or 3 Tesla), time-varying gradient magnetic fields, and radiofrequency (RF) pulses to generate detailed cross-sectional images of the body's internal structures. Unlike CT scanning or plain radiography, MRI uses no ionising radiation, making it the preferred imaging modality for repeated examinations, paediatric patients, and regions sensitive to radiation exposure. The fundamental principle of MRI is nuclear magnetic resonance (NMR): protons in water molecules throughout the body align with the external magnetic field; RF pulses disturb this alignment; and as protons return to equilibrium (relax), they emit RF signals that are spatially encoded by gradient fields and reconstructed by computer into anatomical images. Different tissues relax at different rates (T1 and T2 relaxation times), producing characteristic tissue contrast that allows differentiation of fat, muscle, brain grey and white matter, cartilage, fibrous tissue, fluid, and tumour. Modern MRI sequences include T1-weighted (fat-bright, fluid-dark), T2-weighted (fluid-bright — ideal for oedema and pathology detection), FLAIR (fluid-attenuated inversion recovery — suppresses CSF to reveal brain lesions), diffusion-weighted imaging (DWI — detects acute ischaemia and restricted diffusion in abscesses and tumours), and gadolinium contrast-enhanced imaging (highlighting areas of blood-brain barrier disruption or tumour vascularity). Functional MRI (fMRI) maps brain activation; MR angiography (MRA) images blood vessels; MRCP images bile ducts non-invasively.

MRI is the imaging modality of choice for a wide range of clinical conditions across multiple anatomical regions. Neurological indications include brain tumour diagnosis and treatment planning, detection and characterisation of acute and chronic stroke (DWI sequences detect acute ischaemia within minutes of onset), multiple sclerosis lesion characterisation (white matter plaques are optimally seen on FLAIR), epilepsy protocol MRI for surgical planning, pituitary adenoma evaluation, and assessment of hydrocephalus. Spinal indications include disc herniation and nerve root compression (MRI supersedes CT myelography in most cases), spinal cord compression from tumour or abscess, vertebral fracture assessment, and cauda equina syndrome evaluation (urgent MRI is mandatory to exclude cauda equina compression). Musculoskeletal indications: rotator cuff tears, ligament and meniscus injuries of the knee, hip labral tears, cartilage assessment, bone marrow infiltration, and avascular necrosis. Abdominal and pelvic MRI is preferred for liver characterisation (hepatocellular carcinoma staging), bile duct and pancreatic imaging (MRCP), rectal cancer local staging, prostate cancer detection and staging (mpMRI — multiparametric MRI), uterine fibroid and endometrial pathology assessment, and adrenal lesion characterisation. Breast MRI is used for high-risk screening, extent-of-disease assessment in newly diagnosed breast cancer, and evaluation of breast implant integrity. MRI is contraindicated in patients with pacemakers (except MRI-conditional devices), cochlear implants, certain aneurysm clips, ferromagnetic foreign bodies in the eye, and first-trimester pregnancy (avoided by convention in the absence of urgent clinical need).

MRI does not require special preparation for most scans. For abdominal MRI, a 4–6 hour fast reduces bowel motion artefact; for pelvic MRI, a partially full bladder improves anatomy visualisation. Contrast-enhanced MRI requires IV cannula insertion for gadolinium injection. All metallic objects — jewellery, watches, hearing aids, removable dental appliances, clothing with metallic fastenings — must be removed before entering the scanner room due to the powerful magnetic field. A detailed safety questionnaire screens for all contraindications (implants, metal fragments, prior surgeries). The patient lies supine on a sliding table that moves into the scanner bore — a narrow cylindrical tunnel (typically 60–70 cm bore diameter for standard 1.5T and 3T systems; wide-bore 70+ cm systems and open MRI are available for claustrophobic patients). The relevant body part is positioned within the imaging coil (a radio-frequency detector placed directly over the body part of interest — knee coil, head coil, spine coil, body coil). The patient must remain as still as possible throughout the scan, as movement causes artefact. The scanner produces loud intermittent knocking and banging sounds from gradient coil switching — hearing protection (earplugs or MRI-compatible headphones with music) is provided. The radiographer communicates with the patient from an adjacent control room via an intercom; a hand-held squeeze bulb allows the patient to signal if they need to stop. For contrast-enhanced sequences, gadolinium is injected intravenously during the scan. Scan duration varies from 20 minutes (single joint) to 60–90 minutes (brain and spine, multiparametric prostate MRI, or complex abdominal protocols).

MRI provides unique diagnostic advantages that make it the preferred modality for many clinical questions. Absence of ionising radiation is its most important safety advantage — unlike CT and radiography, MRI does not expose patients to X-ray radiation, making it safe for repeated examinations, pregnant women (with appropriate clinical indication), and paediatric patients. Superior soft tissue contrast resolution is MRI's defining technical strength — it distinguishes between tissues of similar density that are indistinguishable on CT: grey and white brain matter, articular cartilage, tendon and ligament, tumour infiltration into soft tissues, and bone marrow infiltration. Multiparametric prostate MRI (mpMRI) detects clinically significant prostate cancer with a sensitivity of 85–91% and specificity of 80–85% — far superior to PSA alone — and has been incorporated into the standard diagnostic pathway (PROMIS and PRECISION trials) reducing unnecessary biopsies. MRCP (magnetic resonance cholangiopancreatography) provides complete non-invasive imaging of the biliary tree and pancreatic duct, replacing diagnostic ERCP for bile duct assessment in most patients. Cardiac MRI (CMR) provides the gold-standard assessment of myocardial viability (gadolinium late enhancement), cardiomyopathy characterisation, and congenital heart disease anatomy. Functional MRI (fMRI) maps eloquent brain cortex (motor, speech) before neurosurgical tumour resection. No IV contrast is required for many MRI protocols; gadolinium agents, when used, carry a significantly lower risk of adverse reactions than iodinated CT contrast agents.

MRI is an inherently safe examination for most patients when proper safety screening is performed. The absence of ionising radiation is a major safety advantage. However, specific risks and contraindications require attention. The strong magnetic field (1.5–3 Tesla — approximately 30,000–60,000 times the Earth's magnetic field) will attract and displace ferromagnetic objects: pacemakers (unless labelled MRI-conditional), neurostimulators, cochlear implants, certain aneurysm clips, and metallic intraocular foreign bodies are absolute contraindications. These can be displaced, heated, or have their function disrupted by the magnetic field or RF energy. All patients complete a detailed safety questionnaire before every MRI; any history of metallic implants requires implant documentation before entering the scanner. Gadolinium contrast agents are generally safe: the most serious risk is nephrogenic systemic fibrosis (NSF) associated with specific older gadolinium agents in patients with severe renal impairment (eGFR <30) — modern macrocyclic gadolinium agents carry extremely low NSF risk and are the agents of choice. Gadolinium retention in brain tissue (particularly the dentate nucleus and globus pallidus) occurs after repeated administrations — clinical significance is under ongoing investigation; macrocyclic agents show much less retention than linear agents. Claustrophobia affects approximately 1–4% of patients; managed with anxiolytic pre-medication (lorazepam or diazepam) or open/wide-bore MRI scanners. General anaesthesia or deep sedation is required for young children and non-cooperative patients. Acoustic noise from gradient switching (up to 120 dB SPL) is mitigated by hearing protection provided for all patients.

MRI itself requires no recovery time — patients may resume all normal activities immediately after the scan. If sedation or general anaesthesia was used (for young children or severe claustrophobia), appropriate recovery monitoring and driving restrictions for 24 hours apply. If gadolinium contrast was administered, the IV cannula is removed before the patient leaves and no additional recovery is needed; adequate hydration post-scan helps renal clearance. MRI results are reported by a specialist radiologist — a written report is generated and sent to the referring clinician, typically within 24–72 hours for routine scans, faster for urgent examinations. Patients are not given verbal results by MRI staff at the time of scanning; the referring doctor discusses the findings and their clinical implications at a follow-up consultation. If an urgent or unexpected finding is identified (incidental tumour, acute haemorrhage, critical stenosis), the radiologist communicates directly with the referring clinician, who contacts the patient promptly. Patients with an IV cannula site should watch for bruising, swelling, or redness, though significant extravasation of gadolinium is uncommon. No dietary, activity, or medication restrictions apply after standard MRI scanning.